Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7
- 31 May 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (5) , 849-856
- https://doi.org/10.1016/0959-8049(95)00660-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Monoclonal Antibody M3 Used in Tissue Polypeptide–Specific Antigen Assay for the Quantification of Tissue Polypeptide Antigen Recognizes Keratin 18Tumor Biology, 1994
- The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cellsClinical & Experimental Metastasis, 1993
- Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancerThrombosis Research, 1993
- Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicatorEuropean Journal Of Cancer, 1993
- Modulation of the proliferative response of breast cancer cells to growth factors by oestrogenBritish Journal of Cancer, 1992
- Inhibition of Human Breast Cancer Cell (MCF-7) Growthin Vitroby the Somatostatin Analog SMS 201-995: Effects on Cell Cycle Parameters and Apoptotic Cell Death*Endocrinology, 1991
- Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cellsBritish Journal of Cancer, 1989
- Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?Journal of Cellular Biochemistry, 1987
- Autocrine and paracrine growth regulation of human breast cancerJournal of Steroid Biochemistry, 1986
- Differential Metabolism of Large and Small Poly(A) Sequences in the Heterogeneous Nuclear RNA of HeLa CellsProceedings of the National Academy of Sciences, 1974